Hong Kong diabetes fatty liver disease study
Part of Hormones & metabolism clinical trials.
This research study looks at people with type 2 diabetes to learn more about fatty liver disease. By joining, you may help doctors better understand how these conditions are linked and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes
- You are 18 years old or older
- You are able and willing to give written permission to take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have both type 2 diabetes and fatty liver disease to see how these conditions affect heart health over time. By participating, you'll help researchers learn more about lowering your risk of heart problems.
This trial tests a specific medical nutrition therapy diet to see if it can reduce liver fat and improve blood sugar control in people with type 2 diabetes and nonalcoholic fatty liver disease. It may help you manage both conditions with a dietary approach.
This study looks at how early biological aging might increase the chance of developing type 2 diabetes in people with a fatty liver (a condition called MASLD). It uses routine health check-up data to understand the link.
This study looks at how people with fatty liver and type 2 diabetes respond to glucagon, a hormone that helps control blood sugar. It may help researchers understand a condition called 'glucagon resistance' and find better treatments.
This study looks at how fat tissue works differently in people with type 1 diabetes who have extra belly fat, and how that may lead to fat building up in the liver. It compares them to people without diabetes to better understand the link.
This study is building a registry of people in Hong Kong who have both type 2 diabetes and obesity. By joining, you help researchers understand how these conditions interact and find better ways to treat them.
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.